PharmVar Tutorial on CYP2D6 Structural Variation Testing and Recommendations on Reporting
Clinical Pharmacology & Therapeutics · 2023-12 · 114 (6) · 1220-1237
DOI: 10.1002/cpt.3044 ↗At a glance
Übersichtsarbeit in Clinical Pharmacology & Therapeutics, published online on 2023-09-28. Written by Amy J Turner and 16 co-authors. Institution: Department of Pediatrics, Children's Research Institute, The Medical College of Wisconsin, Milwaukee, Wisconsin, USA. Major MEDLINE topics: Cytochrome P-450 CYP2D6. Cited 62 times so far (Crossref); 104 references. The full text is freely available in PubMed Central. Funded by: NHGRI NIH HHS, NIH HHS, National Institutes of Health.
Abstract (original language)
The Pharmacogene Variation Consortium (PharmVar) provides nomenclature for the highly polymorphic human CYP2D6 gene locus and a comprehensive summary of structural variation. CYP2D6 contributes to the metabolism of numerous drugs and, thus, genetic variation in its gene impacts drug efficacy and safety. To accurately predict a patient's CYP2D6 phenotype, testing must include structural variants including gene deletions, duplications, hybrid genes, and combinations thereof. This tutorial offers a comprehensive overview of CYP2D6 structural variation, terms, and definitions, a review of methods suitable for their detection and characterization, and practical examples to address the lack of standards to describe CYP2D6 structural variants or any other pharmacogene. This PharmVar tutorial offers practical guidance on how to detect the many, often complex, structural variants, as well as recommends terms and definitions for clinical and research reporting. Uniform reporting is not only essential for electronic health record‐keeping but also for accurate translation of a patient's genotype into phenotype which is typically utilized to guide drug therapy.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Pediatrics, Children's Research Institute, The Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
- RPRD Diagnostics LLC, Wauwatosa, Wisconsin, USA.
- PharmGenetix GmbH, Niederalm, Austria.
- Let's Get Checked, New York, New York, USA.
- Division of Diagnostic Genomics, Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Department of Medical Genetics, University of Calgary, Calgary, Alberta, Canada.
ORCID profiles: Amy J Turner, Charity Nofziger, Bronwyn E Ramey, Reynold C Ly, Chad A Bousman, José A G Agúndez, Katrin Sangkuhl, Michelle Whirl-Carrillo, Simone Vanoni, Henry M Dunnenberger, Gualberto Ruaño, Martin A Kennedy, Michael S Phillips, Houda Hachad, Teri E Klein, Ann M Moyer, Andrea Gaedigk
Funding
- NHGRI NIH HHS
- NIH HHS
- National Institutes of Health
Cite
APA
Turner, A. J., Nofziger, C., Ramey, B. E., Ly, R. C., Bousman, C. A., Agúndez, J. A. G., Sangkuhl, K., Whirl-Carrillo, M., Vanoni, S., Dunnenberger, H. M., Ruaño, G., Kennedy, M. A., Phillips, M. S., Hachad, H., Klein, T. E., Moyer, A. M., & Gaedigk, A. (2023). PharmVar Tutorial on CYP2D6 Structural Variation Testing and Recommendations on Reporting. Clinical Pharmacology & Therapeutics, 114(6), 1220-1237. https://doi.org/10.1002/cpt.3044
Vancouver
Turner AJ, Nofziger C, Ramey BE, Ly RC, Bousman CA, Agúndez JAG, et al. PharmVar Tutorial on CYP2D6 Structural Variation Testing and Recommendations on Reporting. Clinical Pharmacology & Therapeutics. 2023;114(6):1220-1237. doi:10.1002/cpt.3044
BibTeX
@article{Turner2023,
author = {Turner, Amy J and Nofziger, Charity and Ramey, Bronwyn E and Ly, Reynold C and Bousman, Chad A and Agúndez, José A G and Sangkuhl, Katrin and Whirl-Carrillo, Michelle and Vanoni, Simone and Dunnenberger, Henry M and Ruaño, Gualberto and Kennedy, Martin A and Phillips, Michael S and Hachad, Houda and Klein, Teri E and Moyer, Ann M and Gaedigk, Andrea},
title = {PharmVar Tutorial on CYP2D6 Structural Variation Testing and Recommendations on Reporting},
journal = {Clinical Pharmacology & Therapeutics},
year = {2023},
volume = {114},
number = {6},
pages = {1220--1237},
doi = {10.1002/cpt.3044}
}
EUVIMED